"PBMs are fast pursuing genetics testing as a new core competency, one that comes by way of acquisition," Specialty Pharmacy Solutions consultant Bill Sullivan said. Testing can help PBMs manage high-cost therapies, but the tests' value in containing total health care costs remains unproven.

Full Story:
AIS Health

Related Summaries